Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-02

Clinical Trial Update: Efficacy and Safety of Dexamethasone Nanoparticles Eye Drops in Diabetic Macular Edema [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing efficacy and safety of dexamethasone nanoparticle eye drops for diabetic macular edema has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexamethasone nanoparticle eye drops (dexamethasone nanoparticle formulation)

Snippet

Sponsor: Oculis | Conditions: Diabetic Macular Edema | Phase 2 | Status: COMPLETED | Results posted: 2022-06-02